Home Newsfeeds Prudential Financial Q3 EPS $2.13 Misses $2.22 Estimate

Prudential Financial Q3 EPS $2.13 Misses $2.22 Estimate

Prudential Financial (NYSE:PRU) reported quarterly earnings of $2.13 per share which missed the analyst consensus estimate of $2.22 by 4.05 percent. This is a 43.65 percent decrease over earnings of $3.78 per share from

byBenzinga Newsdesk

November 1, 2022

1 minute read

Piper Sandler Upgrades Mercantile Bank to Overweight, Raises Price Target to $40

By Benzinga Newsdesk

March 7, 6:15 AM

Piper Sandler analyst Brandan Nosal upgrades Mercantile Bank (NASDAQ:MBWM) from Neutral to Overweight and raises the price target from $38 to $40.

MBWM

Dogecoin Layer 2 Crypto Shoots Up 257% In A Week, Bucking Wider Market Trend

By Mehab Qureshi

October 24, 6:28 AM

Dogechain (CRYPTO: DC), a smart contract system for Dogecoin (CRYPTO: DOGE), witnessed a surge of more than 75% in 24 hours leading to Monday.

$DOGE

Dow Gains 50 Points; Global Payments Posts Upbeat Earnings

By Lisa Levin

October 31, 2:32 PM

U.S. stocks turned higher toward the end of trading, with the Dow Jones index gaining around 50 points on Tuesday. The Dow traded up 0.15% to 32,978.85 while the NASDAQ rose 0.20% to 12,814.52. The S&P 500 also rose, gaining, 0.38% to 4,182.85.

CDIO

FDA Approves First Redosable Gene Therapy, Krystal Biotech’s Treatment For Skin Blistering Disorder

By Vandana Singh

May 22, 8:06 AM

The FDA approved Krystal Biotech Inc's (NASDAQ: KRYS) Vyjuvek (beremagene geperpavec-svdt) for the treatment of patients six months of age or older with dystrophic

KRYS

Prudential Financial Q3 EPS $2.13 Misses $2.22 Estimate

Related Posts

Piper Sandler Upgrades Mercantile Bank to Overweight, Raises Price Target to $40

Dogecoin Layer 2 Crypto Shoots Up 257% In A Week, Bucking Wider Market Trend

Dow Gains 50 Points; Global Payments Posts Upbeat Earnings

FDA Approves First Redosable Gene Therapy, Krystal Biotech’s Treatment For Skin Blistering Disorder